MUSTANG BIO, INC. financial data

Symbol
MBIO on Nasdaq
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 129% % 143%
Debt-to-equity 357% %
Return On Equity -75% % -118%
Return On Assets -16% % 92%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $14,800,000 USD -62%
Weighted Average Number of Shares Outstanding, Basic 6,241,658 shares 766%
Weighted Average Number of Shares Outstanding, Diluted 6,241,658 shares 766%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $2,738,000 USD -58%
Operating Income (Loss) $2,779,000 USD 88%
Nonoperating Income (Expense) $444,000 USD -20%
Net Income (Loss) Attributable to Parent $2,335,000 USD 90%
Earnings Per Share, Basic 6 USD/shares 96%
Earnings Per Share, Diluted 6 USD/shares 96%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $18,984,000 USD 439%
Assets, Current $19,361,000 USD 220%
Property, Plant and Equipment, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $0 USD -100%
Other Assets, Noncurrent $0 USD -100%
Assets $19,361,000 USD 169%
Accounts Payable, Current $4,993,000 USD -43%
Liabilities, Current $9,440,000 USD -37%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $9,590,000 USD -39%
Retained Earnings (Accumulated Deficit) $398,106,000 USD -0.59%
Stockholders' Equity Attributable to Parent $9,771,000 USD
Liabilities and Equity $19,361,000 USD 169%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,389,000 USD 74%
Net Cash Provided by (Used in) Financing Activities $7,616,000 USD
Net Cash Provided by (Used in) Investing Activities $1,165,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18,984,000 USD 387%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $152,104,000 USD 3%
Deferred Tax Assets, Gross $152,134,000 USD 2.6%
Operating Lease, Liability $0 USD -100%
Depreciation $420,000 USD -70%
Lessee, Operating Lease, Liability, to be Paid $955,000 USD -69%
Property, Plant and Equipment, Gross $7,694,000 USD 0%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two $439,000 USD -43%
Lessee, Operating Lease, Liability, to be Paid, Year One $516,000 USD -29%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $77,000 USD -86%
Lessee, Operating Lease, Liability, to be Paid, Year Three $269,000 USD -62%
Deferred Tax Assets, Operating Loss Carryforwards $95,131,000 USD 12%
Preferred Stock, Shares Issued 250,000 shares 0%
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $274,000 USD 1.9%
Operating Lease, Payments $86,000 USD -45%
Preferred Stock, Shares Outstanding 250,000 shares 0%
Deferred Tax Assets, Net of Valuation Allowance $30,000 USD -95%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%